Patent · US Expired

Inhibitors for the blood-clotting factor Xa

US6841701B2 · kind B2 · utility

9Cited by

5References

7Claims

0Family size

Assignee

Curacyte AG · DE

Inventors

Jörg Stürzebecher · Erfurt, DE
Torsten Steinmetzer · Jena, DE
Sebastian Künzel · Jena, DE
Andrea Schweinitz · Jena, DE

Key dates

Filing date	Jun 15, 2001
Grant date	Jan 11, 2005
Priority date	—
Expiry date	Jun 15, 2021

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K5/06086
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention relates to derivatives of amidino-benzylamine, especially derivatives of 4-amidino-benzylamine, with two bonded amino acids. These derivatives represent a novel group of highly active and very selective F Xa-inhibitors for treating cardiovascular diseases and thrombotic events.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.